Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/21 cls Avalanche Biotechnologies Inc. (NASDAQ:AAVL) Chardan Capital Gbola Amusa Upgrade Buy (from neutral) 6% $10.62 Amusa upgraded…

    Published on 8/24/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/14 cls Intrexon Corp. (NYSE:XON) JPMorgan Tycho Peterson Downgrade Neutral (from overweight) -20% $47.52 Mizuho Peter Lawson …

    Published on 8/17/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/7 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Piper Jaffray Charles Duncan Downgrade Neutral (from overweight) -20% $39.14 Duncan…

    Published on 8/10/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/31 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Jefferies Eun Yang Upgrade Buy (from hold) 9% $19.13 Yang upgraded, saying the …

    Published on 8/3/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/24 cls Biogen Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Downgrade Market perform (from outperform) -26% $300.03 …

    Published on 7/27/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/17 cls Celgene Corp. (NASDAQ:CELG) BMO Capital Markets Jim Birchenough Price target Outperform 13% $134.52 Deutsche Bank Robyn …

    Published on 7/20/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/10 cls Amgen Inc. (NASDAQ:AMGN) UBS Matthew Roden Downgrade Neutral (from buy) 1% $154.10 Roden also lowered his target to $165 …

    Published on 7/13/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/26 cls Radius Health Inc. (NASDAQ:RDUS) Maxim Group Jason McCarthy Downgrade Neutral (from buy) 7% $63.93 McCarthy downgraded, …

    Published on 6/29/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/19 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Needham Serge Belanger Upgrade Buy (from hold) 54% $20.02 Belanger also set a $27 …

    Published on 6/22/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/12 cls PlasmaTech Biopharmaceuticals Inc. (NASDAQ:PTBI) Roth Capital Partners Elemer Piros New Buy 0% $7.33 Piros initiated …

    Published on 6/15/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/5 cls aTyr Pharma Inc. (NASDAQ:LIFE) BMO Capital Markets Jim Birchenough New Outperform 13% $25.87 JPMorgan Cory Kasimov New …

    Published on 6/8/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/29 cls Blueprint Medicines Corp. (NASDAQ:BPMC) Cowen Eric Schmidt New Outperform -4% $28.69 Wedbush David Nierengarten New …

    Published on 6/1/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/22 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) William Blair Katherine Xu Upgrade Outperform (from market perform) -4% $9.23 …

    Published on 5/25/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/15 cls Dyax Corp. (NASDAQ:DYAX) Oppenheimer Akiva Felt Downgrade Market perform (from outperform) 1% $26.35 Felt also removed his $…

    Published on 5/18/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/8 cls CorMedix Inc. (NYSE-M:CRMD) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) -6% $7.15 Henry downgraded after a…

    Published on 5/11/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/1 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Canaccord John Newman Downgrade Hold (from buy) -11% $95.74 Newman also lowered his …

    Published on 5/4/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/24 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Canaccord Corey Davis Downgrade Hold (from buy) -62% $12.87 Needham Serge Belanger…

    Published on 4/27/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/17 cls Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) H.C. Wainwright Swayampakula Ramakanth Upgrade Buy (from neutral) 23% $0.64 …

    Published on 4/20/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/10 cls Bruker Corp. (NASDAQ:BRKR) Leerink Partners Dan Leonard Upgrade Outperform (from market perform) 7% $20.18 Leonard also …

    Published on 4/13/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/2 cls Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF) ROTH Capital Partners Joseph Pantginis Downgrade Neutral (from buy) -58%…

    Published on 4/6/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/27 cls Exact Sciences Corp. (NASDAQ:EXAS) Goldman Sachs Isaac Ro Downgrade Neutral (from buy) -7% $22.49 Ro also lowered his target…

    Published on 3/30/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/20 cls Actelion Ltd. (SIX:ATLN) UBS Guillaume van Renterghem Downgrade Neutral (from buy) 4% CHF 118.90 van Renterghem downgraded …

    Published on 3/23/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/13 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Cowen Boris Peaker Downgrade Market perform (from outperform) -54% $4.06 Jefferies…

    Published on 3/16/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/6 cls Achaogen Inc. (NASDAQ:AKAO) Credit Suisse Jason Kantor Downgrade Underperform (from outperform) -8% $10.32 Kantor also …

    Published on 3/9/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/27 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Mizuho Mario Corso Upgrade Buy (from neutral) 9% $8.86 Corso also raised his …

    Published on 3/2/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993